Sort
261,768 grants matching “gene therapy”
A nonhuman primate model of stem cell transplantation to understand determinants of post-transplant SIV clearance
$946,593Jonah B. Sacha · Oregon Health & Science University · R01 · FY2020 · AI
Leptin as a Therapy for Alzheimer's Disease
$946,570Nikolaos Tezapsidis · Neurotez, Inc. · R44 · FY2011 · AG
Organoid-based Discovery of Oncogenic Drivers and Treatment Resistance Mechanisms
$946,509Calvin J Kuo · Stanford University · U01 · FY2020 · CA
Alzheimer's Disease Neuroimaging Initiative
$946,418Michael W Weiner · Northern California Institute/Res/Edu · U19 · FY2017 · AG
Investigating the heterogeneity and coordination of hematopoietic stem cells
$946,356Rong Lu · University Of Southern California · R35 · FY2022 · HL
Investigating the heterogeneity and coordination of hematopoietic stem cells
$946,356Rong Lu · University Of Southern California · R35 · FY2023 · HL
Investigating the heterogeneity and coordination of hematopoietic stem cells
$946,356Rong Lu · University Of Southern California · R35 · FY2025 · HL
Investigating the heterogeneity and coordination of hematopoietic stem cells
$946,356Rong Lu · University Of Southern California · R35 · FY2021 · HL
Mechanisms of impaired T-cell mechanosensing of melanoma antigens
$946,295Cheng Zhu · Georgia Institute Of Technology · U01 · FY2020 · CA
Genetic modifiers of Duchenne Muscular Dystrophy
$946,236Kevin M Flanigan · Research Inst Nationwide Children'S Hosp · R01 · FY2022 · NS
TNF-receptors and programmed cell death in regulation of autoimmunity
$946,219Richard M Siegel · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2017 · AR
Organoid-based Discovery of Oncogenic Drivers and Treatment Resistance Mechanisms
$946,126Calvin J Kuo · Stanford University · U01 · FY2017 · CA
Defining the features of T cell response to tumor and self-antigens as predictors of response to checkpoint therapy
$946,097Jane Hoyt Buckner · Benaroya Research Inst At Virginia Mason · R01 · FY2020 · CA
PET, APOE &The Preclinical Course of Alzheimer Disease
$946,093Banner Good Samaritan Medical Center · R01 · FY2004 · MH
Decoding epigenetic scars of smoldering neuroinflammation and CNS complications in people with HIV
$946,093Michael Jay Corley · University Of California, San Diego · R01 · FY2025 · MH
Clinical studies of skeletal diseases
$946,033Michael Collins · Dental & Craniofacial Research · Z01 · FY2007 · DE
Understanding the immune response changes to clinical interventions for Epstein-Barr virus infection prior to lymphoma development in children after organ transplants (UNEARTH)
$945,993Vikas R. Dharnidharka · Rutgers Biomedical And Health Sciences · U01 · FY2025 · CA
Filovirus inhibitors of interferon signaling: virulence factors and drug targets
$945,990Christopher F Basler · Columbia University Health Sciences · U54 · FY2009 · AI
Integrating tumor and stroma to understand and predict treatment response
$945,906Jen Jen Yeh · Univ Of North Carolina Chapel Hill · U01 · FY2022 · CA
Cellular Interactions with Thrombospondin
$945,821David D Roberts · Division Of Clinical Sciences - Nci · ZIA · FY2013 · CA
Optimizing SWELL1 modulators to treat non-alcoholic steatohepatitis
$945,785Daniel J Lerner · Senseion Therapeutics, Inc. · R44 · FY2021 · DK
Biological Basis of Mental Retardation
$945,658Nancy B Schwartz · University Of Chicago · P01 · FY2014 · HD
Development of a DCLK1 siRNA Nanoparticle as Targeted Therapy to Treat Pancreatic Cancer
$945,646Eliseu O. De Oliveira · Coare Holdings, Inc. · R44 · FY2022 · CA
Metabolic Regulators of Tumor Growth and Progression
$945,631Ralph J Deberardinis · Ut Southwestern Medical Center · R35 · FY2018 · CA
Development of Notch1-selective Small Molecule Inhibitor for the Treatment of Cancer
$945,599William Russell Guerrant · Stemsynergy Therapeutics, Inc. · R44 · FY2021 · CA